SHARE
 
David F. Schneider, MD, MS, FACS close
agb10SueNH4

David F. Schneider, MD, MS, FACS Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Schneider is certified by the American Board of Surgery, and he is a member of multiple specialty societies including the American Association of Endocrine Surgeons, the American Thyroid Association, the North American NeuroEndocrine Tumor Society, and the American Association of Clinical Endocrinologists. He specializes in endocrine surgery, treating diseases of the thyroid, parathyroid, and adrenal glands. He utilizes several minimally invasive techniques to treat endocrine disorders (endoscopic thyroidectomy, minimally invasive parathyroidectomy, laparoscopic adrenalectomy, focused exploration for recurrent thyroid cancer).

Specialties

Surgery (General)

Adrenal Adenoma

Adrenocortical Cancer

Cancer Surgeons

Carcinoid Tumor

Conn's Syndrome

Cushing's Syndrome

Endocrine Cancer

Endocrine Surgery

Graves Disease

Hyperparathyroidism

Hyperthyroidism

Hypoparathyroidism

Laparoscopic Adrenalectomy

Minimally Invasive Parathyroidectomy

Modified Radical Neck Dissection

Multiple Endocrine Neoplasia

Myasthenia Gravis

Pheochromocytoma

Substernal Goiter

Thyroid Cancer

Thyroid Nodule

Thyroid, Parathyroid, and Adrenal (Endocrine) Surgery

Thyroidectomy

Clinics

UW Health Surgery at SwedishAmerican
(779) 696-8700 | | Map
UW Health at The American Center
(608) 242-2888 | (844) 607-4800 | Map
UW Health at The American Center
(608) 242-2888 | (844) 607-4800 | Map

UW School of Medicine and Public Health

Department of Surgery

Professional Certifications and Education

Board Certification Clinical Informatics
Surgery
Fellowship

Endocrine Surgery, University of Wisconsin Hospital and Clinics, Madison, WI


Residency Loyola University Medical Center, Maywood, IL
Medical School Loyola University Chicago Stritch School of Medicine, Maywood, IL

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Schneider conducts outcomes research in conjunction with the Wisconsin Surgical Outcomes Program (WiSOR). His research program investigates the optimization of cancer care in the United States with a particular interest in endocrine cancers. This work utilizes large national databases which can impact national healthcare and policy initiatives. He also conducts clinical research working on hyperparathyroidism, thyroid cancer, Graves' Disease, and adrenal disorders.


PubMed Articles
Zhao J Forsythe R Langerman A Melton GB Schneider DF Jackson GP The Value of the Surgeon Informatician. J Surg Res . 2020 Aug;252:264-271
[PubMed ID: 32402396]
Dedhia PH Stoeckl EM McDow AD Pitt SC Schneider DF Sippel RS Long KL Outcomes after completion thyroidectomy versus total thyroidectomy for differentiated thyroid cancer: A single-center experience. J Surg Oncol . 2020 May 28;
[PubMed ID: 32468708]
Kirsch MJ Kohli MW Long KL Pitt SC Schneider DF Sippel RS Dedhia PH Utility of the 10 Hounsfield unit threshold for identifying adrenal adenomas: Can we improve? Am J Surg . 2020 Apr 21;
[PubMed ID: 32359690]
Doubleday AR Novin S Long KL Schneider DF Sippel RS Pitt SC Online Information for Treatment for Low-Risk Thyroid Cancer: Assessment of Timeliness, Content, Quality, and Readability. J Cancer Educ . 2020 Feb 27;
[PubMed ID: 32108292]
Taye A Inabnet WB 3rd Pan S Carty SE Cotton T Czako P Doherty G Gauger P Hanks J McAneny D Milas M Perrier N Rosen J Schneider DF Sharma J Siperstein A Sosa JA Post-thyroidectomy emergency room visits and readmissions: Assessment from the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP). Am J Surg . 2020 Feb 19;
[PubMed ID: 32115176]
Akram S Elfenbein DM Chen H Schneider DF Sippel RS Assessing American Thyroid Association Guidelines for Total Thyroidectomy in Graves' Disease. J Surg Res . 2020 Jan;245:64-71
[PubMed ID: 31401249]
Hughes DT Schneider DF Is it time to redefine cure after parathyroidectomy? Surgery . 2020 Jan;167(1):166-167
[PubMed ID: 31653494]
Schneider DF Making Machine Learning Accessible and Actionable for Clinicians. JAMA Netw Open . 2019 Dec 2;2(12):e1917362
[PubMed ID: 31825497]
Chen SS Zaborek NA Doubleday AR Schaefer SC Long KL Pitt SC Sippel RS Schneider DF Optimizing Levothyroxine Dose Adjustment After Thyroidectomy With a Decision Tree. J Surg Res . 2019 Dec;244:102-106
[PubMed ID: 31279993]
McDow AD Shumway CM Pitt SC Schneider DF Sippel RS Long KL Utility of Early Postoperative Unstimulated Thyroglobulin in Influencing Decision Making in Patients with Papillary Thyroid Carcinoma. Ann Surg Oncol . 2019 Nov;26(12):4002-4007
[PubMed ID: 31267301]
Atruktsang TS Zaborek NA Imbus JR Long K Pitt SC Sippel RS Schneider DF Identifying Predictors of Prolonged Levothyroxine Dose Adjustment After Thyroidectomy. J Surg Res . 2019 Oct;242:166-171
[PubMed ID: 31078901]
Asban A Dombrowsky A Mallick R Xie R Kirklin JK Grogan RH Schneider DF Chen H Balentine CJ Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral. Oncologist . 2019 Sep;24(9):e828-e834
[PubMed ID: 31019019]
Zaborek NA Cheng A Imbus JR Long KL Pitt SC Sippel RS Schneider DF The optimal dosing scheme for levothyroxine after thyroidectomy: A comprehensive comparison and evaluation. Surgery . 2019 Jan;165(1):92-98
[PubMed ID: 30413325]
Perez AA Schneider DF Long KL Pitt SC Sippel RS Timely Evaluation and Management of Primary Hyperparathyroidism in Patients With Kidney Stones. J Surg Res . 2018 Dec;232:564-569
[PubMed ID: 30463775]
Randle RW Bates MF Schneider DF Sippel RS Pitt SC Survival in patients with medullary thyroid cancer after less than the recommended initial operation. J Surg Oncol . 2018 May;117(6):1211-1216
[PubMed ID: 29266278]
Balentine CJ Vanness DJ Schneider DF Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance. Surgery . 2018 Jan;163(1):88-96
[PubMed ID: 29128178]
Bates MF Lamas MR Randle RW Long KL Pitt SC Schneider DF Sippel RS Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease? Surgery . 2018 Jan;163(1):118-123
[PubMed ID: 29128176]
Randle RW Bates MF Long KL Pitt SC Schneider DF Sippel RS Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty. Surgery . 2018 Jan;163(1):68-72
[PubMed ID: 29108701]
Imbus JR Randle RW Pitt SC Sippel RS Schneider DF Machine learning to identify multigland disease in primary hyperparathyroidism. J Surg Res . 2017 Nov;219:173-179
[PubMed ID: 29078878]
Chu YH Hardin H Schneider DF Chen H Lloyd RV MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma. Exp Mol Pathol . 2017 Oct;103(2):229-236
[PubMed ID: 29107050]